↓ Skip to main content

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis

Overview of attention for article published in Arthritis Research & Therapy, January 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

policy
1 policy source
patent
1 patent
googleplus
1 Google+ user

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
41 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis
Published in
Arthritis Research & Therapy, January 2009
DOI 10.1186/ar2802
Pubmed ID
Authors

Raimon Sanmartí, Eduard Graell, Maria L Perez, Guadalupe Ercilla, Odette Viñas, Jose A Gómez-Puerta, Jordi Gratacós, Alejandro Balsa, Maria J Gómara, Marta Larrosa, Juan D Cañete, Isabel Haro

Abstract

Evidence suggests that citrullinated fibrin(ogen) may be a potential in vivo target of anticitrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis (RA). We compared the diagnostic yield of three enzyme-linked immunosorbent assay (ELISA) tests by using chimeric fibrin/filaggrin citrullinated synthetic peptides (CFFCP1, CFFCP2, CFFCP3) with a commercial CCP2-based test in RA and analyzed their prognostic values in early RA.

Mendeley readers

The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Colombia 1 2%
Brazil 1 2%
India 1 2%
United Kingdom 1 2%
Canada 1 2%
Russia 1 2%
Unknown 35 85%

Demographic breakdown

Readers by professional status Count As %
Researcher 10 24%
Student > Ph. D. Student 6 15%
Student > Master 6 15%
Student > Postgraduate 4 10%
Other 3 7%
Other 6 15%
Unknown 6 15%
Readers by discipline Count As %
Medicine and Dentistry 17 41%
Biochemistry, Genetics and Molecular Biology 5 12%
Agricultural and Biological Sciences 5 12%
Psychology 1 2%
Nursing and Health Professions 1 2%
Other 4 10%
Unknown 8 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 July 2018.
All research outputs
#2,117,741
of 13,205,256 outputs
Outputs from Arthritis Research & Therapy
#552
of 2,150 outputs
Outputs of similar age
#48,719
of 291,392 outputs
Outputs of similar age from Arthritis Research & Therapy
#12
of 53 outputs
Altmetric has tracked 13,205,256 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,150 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 291,392 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.